McDonald Capital Investors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
McDonald Capital Investors's DICE Position: Q3 2023 in Review
McDonald Capital Investors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 5,682 shares — an estimated $264K sold.
McDonald Capital Investors first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $264K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.
- McDonald Capital Investors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- McDonald Capital Investors sold 5,682 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $264K.
- McDonald Capital Investors first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
- McDonald Capital Investors's DICE Therapeutics, Inc. Common Stock position peaked at $264K in Q2 2023.
- 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.
Based on McDonald Capital Investors's 13F filing for Q3 2023, filed 27 Oct 2023.